Press Releases

Filter Releases
 
Press Releases
Date Title and Summary View
Sep 19, 2011 WALTHAM, Mass., Sep 19, 2011 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO) today reported the initiation of commercial shipments of NC-stat® DPNCheck™, a fast, accurate and quantitative point-of-care test for the evaluation of syst...
Sep 19, 2011 WALTHAM, Mass., Sep 19, 2011 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it has received a letter from The NASDAQ Stock Market LLC ("NASDAQ") indicating that it has regained compliance with the minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2) for continued listing on The...
Sep 7, 2011 WALTHAM, Mass., Sep 07, 2011 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO), a science-based health care company improving patient care through neurotechnology, today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the Rodman & Renshaw Annual Global...
Sep 1, 2011 WALTHAM, Mass., Sep 01, 2011 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO), a science-based health care company improving patient care through neurotechnology, today announced the effectiveness of a one-for-six reverse stock split of its common stock. The reverse stock split, which was previously approved by t...
Aug 2, 2011 WALTHAM, Mass., Aug 02, 2011 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO), a science-based health care company improving patient care through neurotechnology, today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the Canaccord Genuity Growth Conferenc...
Jul 28, 2011 WALTHAM, Mass., Jul 28, 2011 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO), a science-based health care company improving patient care through neurotechnology, today reported business and financial highlights for the quarter and six months ended June 30, 2011. NeuroMetrix is focused on apply...
Jul 21, 2011 WALTHAM, Mass., Jul 21, 2011 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2011 second quarter financial results before the opening of the market on July 28, 2011. The Company will host a conference call at 8:00 a.m., Eastern time on July 28, 2011 to discuss its second quarter ...
Jul 6, 2011 WALTHAM, Mass., Jul 06, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it met its planned marketing launch date for NC-stat®|DPNCheck™, which is a fast, accurate, and quantitative test for the evaluation of systemic neu...
Jun 20, 2011 WALTHAM, Mass., Jun 20, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it expects to meet its planned launch date for its latest product, NC-stat®|DPNCheck™, which is a fast, accurate, and quantitative test for the evaluation of sy...
Jun 15, 2011 WALTHAM, Mass. & FT LAUDERDALE, Fla., Jun 15, 2011 (BUSINESS WIRE) --Nipro Diagnostics, Inc. and NeuroMetrix, Inc. (Nasdaq: NURO) today announced their collaboration to evaluate opportunities for NC-stat® | DPNCheck™ in retail medic...
Jun 1, 2011 WALTHAM, Mass., Jun 01, 2011 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it will exhibit at the annual meeting of The Endocrine Society in Boston on June 4-6, 2011. The exhibition will include a demonstration of its newest product - NC-stat®...
Apr 28, 2011 WALTHAM, Mass., Apr 28, 2011 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO), a science-based health care company transforming patient care through neurotechnology, today reported business and financial highlights for the quarter ended March 31, 2011. NeuroMetrix has focused its business strategy on t...
Apr 21, 2011 WALTHAM, Mass., Apr 21, 2011 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2011 first quarter financial results before the opening of the market on April 28, 2011. The Company will host a conference call at 8:00 am eastern time on April 28, 2011 to discuss its first quarter fin...
Apr 13, 2011 WALTHAM, Mass., Apr 13, 2011 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it will preview its newest product - NC-stat® | DPNCheck™ - at the Annual Meeting of the American Association of Clinical Endocrinologi...
Mar 21, 2011 WALTHAM, Mass., Mar 21, 2011 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it has formed a scientific advisory board of international experts to help guide the scientific, clinical and market development of its diabetic peripheral neuropathy (DPN) test. The device is a modified version of ...
= add release to Briefcase